Information Provided By:
Fly News Breaks for March 2, 2015
MDT, NUVA
Mar 2, 2015 | 12:59 EDT
Wells Fargo views today's appeals court ruling as a positive for NuVasive (NUVA) since it believes the final damages will likely be less than the original award of $101M. Wells notes subsequent rulings should have a limited impact on NuVasive's business since the most significant Medtronic (MDT) patent expired in February. It has an Outperform rating on NuVasive.
News For NUVA;MDT From the Last 2 Days
There are no results for your query NUVA;MDT
I agree to the thefly.com's disclaimer & terms of use
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.